3 ML insulin aspart, human 100 UNT/ML Pen Injector [NovoLog]
- RxCUI
- 1653204
- RxNorm name
- 3 ML insulin aspart, human 100 UNT/ML Pen Injector [NovoLog]
- Display name
- 3 ML insulin aspart, human 100 UNT/ML Pen Injector [NovoLog]
- Full name
- 3 ML insulin aspart, human 100 UNT/ML Pen Injector [NovoLog]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:54
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 020986 | Novolog | insulin aspart | 351(a) | Rx | 2026-07-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| NOVOLOG | INSULIN ASPART | A-S Medication Solutions | 13891e5a-e57a-46e8-911c-2f680352b52b | 2023-12-15 | Warnings, Adverse reactions | 1653204 |
| NOVOLOG | INSULIN ASPART | A-S Medication Solutions | e172b4f8-9b25-4019-8e09-afc10b2f30c9 | 2023-12-09 | Warnings, Adverse reactions | 1653204 |
| Insulin Diluting Medium for NovoLog | WATER INJECTION | Novo Nordisk | 3a1e73a2-3009-40d0-876c-b4cb2be56fc5 | 2023-02-28 | Warnings, Adverse reactions | 1653204 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 3a1e73a2-3009-40d0-876c-b4cb2be56fc5 | NovoLOG 100 UNT/ML in 3 ML Pen Injector [PSN] · 3 ML insulin aspart, human 100 UNT/ML Pen Injector [NovoLog] [SBD] · 3 ML NovoLog 100 UNT/ML Pen Injector [SY] · NovoLog FlexPen 100 UNT/ML per 3 ML Pen Injector [SY] · NovoLog FlexTouch 100 UNT/ML per 3 ML Pen Injector [SY] | 5 | 34 | These highlights do not include all the information needed to use NOVOLOG safely and effectively. See full prescribing information for NOVOLOG. NOVOLOG ® (insulin aspart) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2000 | 20230228 |
| e172b4f8-9b25-4019-8e09-afc10b2f30c9 | NovoLOG 100 UNT/ML in 3 ML Pen Injector [PSN] · 3 ML insulin aspart, human 100 UNT/ML Pen Injector [NovoLog] [SBD] · 3 ML NovoLog 100 UNT/ML Pen Injector [SY] · NovoLog FlexPen 100 UNT/ML per 3 ML Pen Injector [SY] · NovoLog FlexTouch 100 UNT/ML per 3 ML Pen Injector [SY] | 5 | 28 | These highlights do not include all the information needed to use NOVOLOG safely and effectively. See full prescribing information for NOVOLOG. NOVOLOG ® (insulin aspart) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2000 | 20231209 |
| 13891e5a-e57a-46e8-911c-2f680352b52b | NovoLOG 100 UNT/ML in 3 ML Pen Injector [PSN] · 3 ML insulin aspart, human 100 UNT/ML Pen Injector [NovoLog] [SBD] · 3 ML NovoLog 100 UNT/ML Pen Injector [SY] · NovoLog FlexPen 100 UNT/ML per 3 ML Pen Injector [SY] · NovoLog FlexTouch 100 UNT/ML per 3 ML Pen Injector [SY] | 5 | 6 | These highlights do not include all the information needed to use NOVOLOG safely and effectively. See full prescribing information for NOVOLOG. NOVOLOG ® (insulin aspart) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2000 | 20231215 |
| cd88e313-6193-4413-beff-7d955580060d | NovoLOG 100 UNT/ML in 3 ML Pen Injector [PSN] · 3 ML insulin aspart, human 100 UNT/ML Pen Injector [NovoLog] [SBD] · 3 ML NovoLog 100 UNT/ML Pen Injector [SY] · NovoLog FlexPen 100 UNT/ML per 3 ML Pen Injector [SY] · NovoLog FlexTouch 100 UNT/ML per 3 ML Pen Injector [SY] | 5 | 1 | These highlights do not include all the information needed to use NovoLog safely and effectively. See full prescribing information for NovoLog. NovoLog ® (insulin aspart [rDNA origin] injection) solution for subcutaneous use Initial U.S. Approval: 2000 | 20130723 |